0000014272-19-000102.txt : 20190405
0000014272-19-000102.hdr.sgml : 20190405
20190405163238
ACCESSION NUMBER: 0000014272-19-000102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190403
FILED AS OF DATE: 20190405
DATE AS OF CHANGE: 20190405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynch Thomas J. Jr.
CENTRAL INDEX KEY: 0001474056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 19735494
MAIL ADDRESS:
STREET 1: 800 HOWARD AVENUE
STREET 2: YALE PHYSICIANS BUILDING, 2ND FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06519
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: 14 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: 14 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4
1
wf-form4_155449634349912.xml
FORM 4
X0306
4
2019-04-03
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001474056
Lynch Thomas J. Jr.
BRISTOL-MYERS SQUIBB COMPANY
430 E. 29TH STREET, 14 FLOOR
NEW YORK
NY
10016
0
1
0
0
EVP & Chief Scientific Officer
Common Stock, $0.10 par value
2019-04-03
4
M
0
6296
0
A
23868.964
D
Common Stock, $0.10 par value
2019-04-03
4
F
0
3351
46.88
D
20517.964
D
Common Stock, $0.10 par value
2019-04-03
4
M
0
5298
0
A
25815.964
D
Common Stock, $0.10 par value
2019-04-03
4
J
0
773
0
D
25042.964
D
Common Stock, $0.10 par value
2019-04-03
4
F
0
2820
46.88
D
22222.964
D
Restricted Stock Units
2019-04-03
4
M
0
6296
0
D
2021-04-03
Common Stock, $0.10 par value
6296.0
12592
D
Market Share Units
2019-04-03
4
M
0
5298
0
D
2021-04-03
Common Stock, $0.10 par value
5298.0
12143
D
Shares withheld for payment of taxes upon vesting of awards.
Represents vesting of one-quarter of market share units granted on April 3, 2017.
Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.
Each restricted stock unit converts into one share of common stock upon vesting.
Represents vesting of one-quarter of restricted stock units granted on April 3, 2017.
Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
/s/ Lisa A. Atkins, attorney-in-fact for Thomas J. Lynch, Jr. M.D.
2019-04-05